Follow The Filings

RANI Rani Therapeutics Holdings Inc.

Health Care, filed as RANI THERAPEUTICS HLDGS INC (COM CL A), Equity As of 2026 Q3 so far: 135 of 140 managers we track have filed Quote on Google Finance, opens in a new tab

  • 1 Owner
  • $16K

Who owns RANI

Sorted by value, long equity only, as of 2026 Q3.

History
Farallon Capital Management <0.01% Hold 20,700 $16K History

Insider trades

Open-market buys and sales by RANI's executives, directors and 10% owners in the last 12 months, from their Form 4s

All RANI insider trades
  • $50K bought by 2 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Mir A. Imran Director
    Buy
    $25K 36,000 shares at $0.6900 +1.7% to stake
    Traded Jul 21 Filed Jul 23
  2. Talat Imran CEO
    Buy
    $25K 35,000 shares at $0.7200 +8.1% to stake
    Traded Jul 17 Filed Jul 21
  3. Mir A. Imran Director
    Buy
    $1.3M 2,083,334 shares at $0.6100 New stake
    Traded Oct 23, 2025 Filed Oct 27, 2025
  4. South Cone Investments Limited Partnership 10% owner
    Sale
    $15.7M 5,923,000 shares at $2.65 71% of stake
    Traded Oct 20–21 Filed Oct 22, 2025

Also filed in the last 12 months, not counted as buying or selling: 7 share withholdings for taxes and 1 sale to cover taxes.

SEC filings

Recent issuer filings from EDGAR, 23 shown.

Filed Form Detail Links
8-K 3.01
SCHEDULE 13G/A —
10-Q
8-K 2.02,9.01
SCHEDULE 13G/A —
8-K 2.02,9.01
10-Q
8-K 5.02
SCHEDULE 13G/A —
8-K 5.02,9.01
8-K 5.07
SCHEDULE 13D/A —
424B5
8-K 8.01,9.01
SCHEDULE 13G/A —
8-K 2.02,3.01,5.02,9.01
10-Q
SCHEDULE 13G —
DEF 14A
DEFA14A DEFA 14A
SCHEDULE 13G/A —
8-K 2.02,9.01
10-K

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue — $1.03M $1.63M
Net income -$33.97M -$30.02M -$29.67M
Net margin * — -2920.0% -1817.1%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $50.85M $29.74M $53.32M
Total non-current assets * $7.07M $6.89M $5.3M
Total assets $57.92M $36.63M $58.62M
Total current liabilities $7.99M $19.89M $12.67M
Total non-current liabilities * $24.48M $13.25M $4.44M
Total equity $12.87M $1.99M $33.01M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$51.24M -$35.5M -$18.71M
Cash from investing $29.86M $19.81M -$7.03M
Cash from financing $0.233M $13.58M $40.3M
Net change in cash -$21.14M -$2.1M $14.56M

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf